Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
27.21
+0.03 (0.11%)
Dec 12, 2025, 9:31 AM EST - Market open
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $3.97 billion as of December 12, 2025. Its market cap has increased by 76.92% in one year.
Market Cap
3.97B
Enterprise Value
3.84B
1-Year Change
76.92%
Ranking
Category
Stock Price
$27.21
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $3.97B, an increase of 127.32%. That is a compound annual growth rate of 19.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 4.32B | 95.59% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
| May 28, 2021 | 1.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 885.71B |
| Johnson & Johnson | 491.47B |
| AbbVie | 394.30B |
| UnitedHealth Group | 293.64B |
| AstraZeneca | 280.62B |
| Novartis AG | 254.28B |
| Merck & Co. | 241.67B |
| Thermo Fisher Scientific | 213.10B |